Patent Assignment
Reel/Frame 039254/0521
Security Interest
Recorded: 2016-07-05
Pages: 24
Assignor
FORUM PHARMACEUTICALS INC.
Executed: 2016-05-23
Assignee
FMR LLC
155 SEAPORT BLVD., BOSTON, MASSACHUSETTS, 02210
Covered Properties
(6)
Methods for Treating Cognitive Disorders Using Inhibitors of Histone Deacetylase
PCT:
PCT/US2009/042818 ↗
5- and 6-Membered Heterocyclic Compounds
PCT:
PCT/US2009/048617 ↗
Treatment of Cognitive Disorders with (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
PCT:
PCT/US2009/065173 ↗
A Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide Hydrochloride Monohydrate
PCT:
PCT/US2011/036844 ↗
Methods of Targeted Treatment of Frontotemporal Lobar Degeneration
PCT:
PCT/US2012/030527 ↗
Methods of Maintaining, Treating or Improving Cognitive Function
PCT:
PCT/US2013/039692 ↗
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 29, 2010
From: ROGERS, KATHRYN; PATZKE, HOLGER
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 024624/0080 →
Assignment of Assignor's Interest
Oct 15, 2014
From: KOENIG, GERHARD; HILT, DANA C.
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 033954/0586 →
Change of Name
Oct 15, 2014
From: ENVIVO PHARMACEUTICALS, INC.
To: FORUM PHARMACEUTICALS, INC.
Reel/Frame 034002/0955 →